Ability of physicians to diagnose and manage illness due to category A bioterrorism agents
- PMID: 16186470
- DOI: 10.1001/archinte.165.17.2002
Ability of physicians to diagnose and manage illness due to category A bioterrorism agents
Abstract
Background: Early recognition of a terrorist attack with biologic agents will rely on physician diagnosis. Physicians' ability to diagnose and care for patients presenting after a bioterror event is unknown. The role of online case-based didactics to measure and improve knowledge in the diagnosis and treatment of these patients is unknown.
Methods: A multicenter online educational intervention was completed by 631 physicians at 30 internal medicine residency programs in 16 states and Washington, DC, between July 1, 2003, and June 10, 2004. Participants completed a pretest, assessing ability to diagnose and manage potential cases of smallpox, anthrax, botulism, and plague. A didactic module reviewing diagnosis and management of these diseases was then completed, followed by a posttest. Pretest performance measured baseline knowledge. Posttest performance compared with pretest performance measured effectiveness of the educational intervention. Results were compared based on year of training and geographic location of the residency program.
Results: Correct diagnoses of diseases due to bioterrorism agents were as follows: smallpox, 50.7%; anthrax, 70.5%; botulism, 49.6%; and plague, 16.3% (average, 46.8%). Correct diagnosis averaged 79.0% after completing the didactic module (P<.001). Correct management of smallpox was 14.6%; anthrax, 17.0%; botulism, 60.2%; and plague, 9.7% (average, 25.4%). Correct management averaged 79.1% after completing the didactic module (P<.001). Performance did not differ based on year of training (P = .54) or geographic location (P = .64). Attending physicians performed better than residents (P<.001).
Conclusions: Physician diagnosis and management of diseases caused by bioterrorism agents is poor. An online didactic module may improve diagnosis and management of diseases caused by these agents.
Similar articles
-
Recognition and management of bioterrorism infections.Am Fam Physician. 2003 May 1;67(9):1927-34. Am Fam Physician. 2003. PMID: 12751654 Review.
-
Histopathology and immunohistochemistry in the diagnosis of bioterrorism agents.J Histochem Cytochem. 2006 Jan;54(1):3-11. doi: 10.1369/jhc.5R6756.2005. Epub 2005 Sep 7. J Histochem Cytochem. 2006. PMID: 16148309 Review.
-
Clinical management of potential bioterrorism-related conditions.N Engl J Med. 2015 Mar 5;372(10):954-62. doi: 10.1056/NEJMra1409755. N Engl J Med. 2015. PMID: 25738671 Review.
-
Threats in bioterrorism. I: CDC category A agents.Emerg Med Clin North Am. 2002 May;20(2):273-309. doi: 10.1016/s0733-8627(02)00005-6. Emerg Med Clin North Am. 2002. PMID: 12120480 Review.
-
Physicians' understanding of the regulation of dietary supplements.Arch Intern Med. 2007 May 14;167(9):966-9. doi: 10.1001/archinte.167.9.966. Arch Intern Med. 2007. PMID: 17502539
Cited by
-
Septicemic plague in a community hospital in California.Am J Trop Med Hyg. 2008 Jun;78(6):868-71. Am J Trop Med Hyg. 2008. PMID: 18541761 Free PMC article.
-
A Multiplex PCR/LDR Assay for the Simultaneous Identification of Category A Infectious Pathogens: Agents of Viral Hemorrhagic Fever and Variola Virus.PLoS One. 2015 Sep 18;10(9):e0138484. doi: 10.1371/journal.pone.0138484. eCollection 2015. PLoS One. 2015. PMID: 26381398 Free PMC article.
-
Discordant Brucella melitensis antigens yield cognate CD8+ T cells in vivo.Infect Immun. 2010 Jan;78(1):168-76. doi: 10.1128/IAI.00994-09. Epub 2009 Nov 2. Infect Immun. 2010. PMID: 19884330 Free PMC article.
-
Deliberate release: Plague - A review.J Biosaf Biosecur. 2020 Mar;2(1):10-22. doi: 10.1016/j.jobb.2020.02.001. Epub 2020 Mar 30. J Biosaf Biosecur. 2020. PMID: 32835180 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical